Connect to other sites within the UBM Medica Network
High Variability in Diagnosis of Dense Breasts
A recent study found that radiologists differ in their interpretation of whether a woman has dense breasts based on mammography.
IVF Did Not Increase Breast Cancer Incidence
Results from a long-term study indicated that undergoing fertility treatment with in vitro fertilization did not increase women’s risk for breast cancer compared with women in the general population.
Study Offers Limited Support for Mediterranean Diet’s Effect on Breast Cancer Incidence
A meta-analysis found that a Mediterranean diet with no limits on fat intake may reduce the incidence of breast cancer, as well as several other outcomes, compared to other diets.
Chemotherapy Plus Bevacizumab Promising in Advanced TNBC
A triplet regimen including paclitaxel, capecitabine, and bevacizumab showed efficacy and safety in women with advanced triple-negative breast cancer.
Acupressure Can Ease Symptoms of Breast Cancer
Acupressure, a technique derived from acupuncture, helped improve sleep and relieved chronic fatigue experienced by women treated for breast cancer.
A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma
A 40-year-old woman noted a large mass in her right breast. A diagnostic mammogram and ultrasound confirmed a 3.4-cm mass with associated microcalcifications.
Everolimus/Exemestane Deemed Manageable in Advanced Breast Cancer
The combination of everolimus and exemestane was deemed generally tolerable with a manageable safety profile in women with advanced HR-positive/HER2-negative breast cancer.
Palbociclib, Fulvestrant Delays HR-Positive Breast Cancer Progression
The addition of palbociclib to fulvestrant delayed disease progression in women with HR-positive, HER2-negative metastatic breast cancer.
Anastrozole Trumps Tamoxifen in DCIS
Treatment of postmenopausal DCIS patients with the aromatase inhibitor anastrozole resulted in higher breast cancer–free survival rates compared with treatment with tamoxifen.
Majority of Metaplastic Breast Cancers May Be Targetable
In this video from MBCC we discuss a poster presentation on genomic and protein alterations in 126 triple-negative metaplastic breast cancers.
Impact of ALTTO Results on Patients With HER2-Positive Breast Cancer
In this video, Dr. Sledge discusses what the negative results of the ALTTO trial mean for women with HER2-positive breast cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.